Pharma Bio Serv Stock Price Prediction
| PBSV Stock | USD 0.48 0.02 4.00% |
Oversold Vs Overbought
46
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Pharma-Bio Serv based on different types of headlines from major news networks to social media. Using Pharma-Bio Serv hype-based prediction, you can estimate the value of Pharma Bio Serv from the perspective of Pharma-Bio Serv response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Pharma-Bio Serv. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Pharma-Bio Serv to buy its otc stock at a price that has no basis in reality. In that case, they are not buying Pharma-Bio because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Pharma-Bio Serv after-hype prediction price | USD 0.48 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Pharma-Bio |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pharma-Bio Serv's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pharma-Bio Serv After-Hype Price Prediction Density Analysis
As far as predicting the price of Pharma-Bio Serv at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Pharma-Bio Serv or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Pharma-Bio Serv, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Pharma-Bio Serv Estimiated After-Hype Price Volatility
In the context of predicting Pharma-Bio Serv's otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Pharma-Bio Serv's historical news coverage. Pharma-Bio Serv's after-hype downside and upside margins for the prediction period are 0.02 and 5.25, respectively. We have considered Pharma-Bio Serv's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Pharma-Bio Serv is out of control at this time. Analysis and calculation of next after-hype price of Pharma Bio Serv is based on 3 months time horizon.
Pharma-Bio Serv OTC Stock Price Prediction Analysis
Have you ever been surprised when a price of a OTC Stock such as Pharma-Bio Serv is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pharma-Bio Serv backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Pharma-Bio Serv, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.02 | 4.77 | 0.00 | 0.00 | 0 Events / Month | 11 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.48 | 0.48 | 0.00 |
|
Pharma-Bio Serv Hype Timeline
Pharma Bio Serv is at this time traded for 0.48. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Pharma-Bio is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at -0.02%. %. The volatility of related hype on Pharma-Bio Serv is about 2474.35%, with the expected price after the next announcement by competition of 0.48. About 65.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.15. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pharma Bio Serv last dividend was issued on the 24th of February 2022. Given the investment horizon of 90 days the next projected press release will be within a week. Check out Pharma-Bio Serv Basic Forecasting Models to cross-verify your projections.Pharma-Bio Serv Related Hype Analysis
Having access to credible news sources related to Pharma-Bio Serv's direct competition is more important than ever and may enhance your ability to predict Pharma-Bio Serv's future price movements. Getting to know how Pharma-Bio Serv's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Pharma-Bio Serv may potentially react to the hype associated with one of its peers.
Pharma-Bio Serv Additional Predictive Modules
Most predictive techniques to examine Pharma-Bio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pharma-Bio using various technical indicators. When you analyze Pharma-Bio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Pharma-Bio Serv Predictive Indicators
The successful prediction of Pharma-Bio Serv stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Pharma Bio Serv, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Pharma-Bio Serv based on analysis of Pharma-Bio Serv hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Pharma-Bio Serv's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Pharma-Bio Serv's related companies.
Story Coverage note for Pharma-Bio Serv
The number of cover stories for Pharma-Bio Serv depends on current market conditions and Pharma-Bio Serv's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Pharma-Bio Serv is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Pharma-Bio Serv's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Pharma-Bio Serv Short Properties
Pharma-Bio Serv's future price predictability will typically decrease when Pharma-Bio Serv's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Pharma Bio Serv often depends not only on the future outlook of the potential Pharma-Bio Serv's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pharma-Bio Serv's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 22.9 M | |
| Dividends Paid | 3.4 M | |
| Forward Annual Dividend Rate | 0.07 | |
| Shares Float | 12.3 M |
Additional Tools for Pharma-Bio OTC Stock Analysis
When running Pharma-Bio Serv's price analysis, check to measure Pharma-Bio Serv's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma-Bio Serv is operating at the current time. Most of Pharma-Bio Serv's value examination focuses on studying past and present price action to predict the probability of Pharma-Bio Serv's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma-Bio Serv's price. Additionally, you may evaluate how the addition of Pharma-Bio Serv to your portfolios can decrease your overall portfolio volatility.